| Sources | Names Used |
|---|---|
| CCLE, FIMM | Irinotecan |
| gCSI | irinotecan |
| GRAY | CPT-11 |
| PharmacoGx | Irinotecan |
| Database | Identifier |
|---|---|
| Smiles: | CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)C5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7 |
| Inchikey: | UWKQSNNFCGGAFS-XIFFEERXSA-N |
| Pubchem: | 60838 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DIP2A | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | CCDC159 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | EFTUD2 | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | GRB7 | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | NAT10 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | TPPP | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | LSMEM1 | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | MYBL2 | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | DUS3L | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | HS6ST3 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
